Efficacy and Safety of Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder.
Phase of Trial: Phase III
Latest Information Update: 02 Jul 2012
At a glance
- Drugs Etoricoxib (Primary)
- Indications Musculoskeletal pain; Rheumatic disorders
- Focus Therapeutic Use
- 02 Jul 2012 Actual patient number is 45 according to ClinicalTrials.gov.
- 02 Jul 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Jul 2012 Drug company (Merck) added to the associations as reported by ClinicalTrials.gov.